Socket Graft

For use when all 4 bony walls are intact after extraction

Socket Graft

Insurance Codes

7953 Bone Replacement Graft (Socket Graft)
4267 GTR-Non-Resorbable Membrane

What makes this synthetic graft material so unique?

Socket Graft is a dual phase calcium phosphate based synthetic bone graft material designed to quickly treat the extraction socket, retain alveolar bone, stimulate bone formation, reduce post-operative complications, and resorb quickly and completely. It contains no human or animal tissue and carries no potential for allergic or inflammatory reactions.

This innovative delivery system allows for ease of application, but most importantly, produces superior bone quality with bone to implant integration due to its osteogenic properties. This material quickly regenerates bone while it completely resorbs and becomes replaced by your patient’s own bone. A faster and healthier bone regeneration sequence allows for an implant to be placed sooner than if other bone grafts were used. Implant placement at 4 weeks, 6 weeks, 12 weeks or more can now be achieved with predictable results.

For the injectable version of this graft material, jump to Socket Graft Injectable

Product Tip:
Hydrating Socket Graft

The shipping process in combination with time in the freezer can on occasion cause Socket Graft or Socket Graft Plus to dry and become difficult to handle. While drying has no negative effect on the performance of the material, it makes it very difficult to apply.

If you find your graft material is dry, there is an easy fix. Simply add moisture by applying a few drops of local anesthesia to the petals of graft and they are back to an easily manageable putty. While we do not advise adding any chemical to be placed in the socket during socket grafting, adding local anesthetic to the graft will have no negative effect on the graft’s performance.

Local anesthesia perfuses the tissues and this local anesthesia will also find its way into the socket, so adding a few drops to the graft material has no negative effect on bone growth and possibly could result in a more effective post-operative anesthesia.

Product Demonstration

  • Remove the graft material from the freezer when ready to apply, not allowing the material to thaw
  • Open the white pouch and dispense the clear package onto the surgical site
  • Before opening the clear pouch, bend the tray to loosen the petals
  • Cut the clear package and use the bone graft immediately
  • Debride the socket, apply the first frozen petal into the socket, allow a few seconds for it to begin to thaw in the socket
  • As the second petal is applied, the sequential petals will also thaw but remain malleable for packing
  • If the graft material becomes wet, apply a sterile gauze over the graft and pack firmly to dry and condense the material
  • Cutting the petals in half will facilitate placement when approaching the crest
  • After the socket is packed, use a dense PTFE with Oral Bond (dental adhesive) to cover the graft
  • Place Oral Bond on the sutures and margins of the membrane to create a hermetic seal
  • Remove the sutures in 2 weeks and the membrane in 1 month
  • As an alternative, please use our sutureless membrane technique using Oral Bond

Socket Graft 0.5cc is packaged as three (3) petals of graft material in a sterile, medical grade silicone tray (triangular)

Socket Graft 1cc is packaged as six (6) petals of graft material in a sterile, medical grade silicone tray (hexagonal)

Our grafts are categorized by the FDA as both a medical device and a drug. In fact, our bone grafts are the only grafts on the market that the FDA allows to claim that the grafts stimulate osteogenesis.

Furthermore, our grafts are the only grafts expressly cleared by the FDA for implant placement.

All compounds are synthesized ultra-pure, ensuring the process of bone growth is safe, predictable, and effective.

  • No Allergic Reaction
  • No Inflammatory Response
  • No Human or Animal Products

Strengthen Your Practice

Socket Graft will change your practice when your patients realize our technology is available to them. Your patients now have a choice between a chemically pure, FDA cleared bone graft or the frequently off-putting choice of cadaver tissue. Resorbable synthetics and autografts are the only bone grafts that produce normal bone. Normal bone is the only type of bone that has been shown to support an implant for a lifetime.

Offer your patients a bone graft material that is safe, will not cause an inflammatory reaction, is non-allergenic, and contains NO human or animal product.

How Does SL Factor Work?

SteinerBio has the only bone grafts on the market that contain a drug that changes the physiology of a bone’s osteoblasts to stimulate osteogenesis. SL Factor, our patented organic compound, enters through the membrane of the osteoblasts and results in the following metabolic activities:

  • SL Factor is absorbed by the osteoblasts
  • SL Factor activates over 300 genes that stimulate the process of bone formation
  • BMP2 and RUNX2 production increases two-fold and reduces osteoclast formation by inhibiting the production of RANK ligand
  • Osteocalcin accumulation is enhanced in the extracellular matrix resulting in excellent mineralization
  • While stored in the osteoblast, SL Factor continues to stimulate bone growth after the synthetic matrix has been resorbed
  • Adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression is inhibited
  • Inflammation is reduced by inhibiting prostaglandin synthesis

Socket Graft provides the organic and inorganic molecules a bone needs to regrow faster, stronger, healthier, and more vital. SteinerBio is the only bone graft company that uses a biologically active compound to physiologically stimulate bone growth, making our products exceptional within regenerative medicine. Our patented SL Factor in our bone graft material targets the osteoblasts within the patient’s bone, initiating the bone regeneration process.

“Modern beta tricalcium phosphate bone grafts perform as well or better than allografts or autografts. The negatives of autograft morbidity and cadaver harvesting makes high performing βTCP a superior choice.”


American Society for Bone and Mineral Research (ASBMR)

Tissue Engineering and Regenerative Medicine International Society (TERMIS)

American Academy of Implant Dentistry (AAID)